FDA Clearance Tracker · P030039-S020
Coseal Surgical Sealant
Last checked: Nov 20, 2026Latest source record: Mar 22, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 22, 2018
Approved
Time to decision
108 days
Received Dec 4, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030039-S020
- Device name
- Coseal Surgical Sealant
- Applicant
- Baxter Bio Science
- Applicant location
- Round Lake,, IL
- Received
- Dec 4, 2017
- Decided
- Mar 22, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P030039
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Baxter S.A., Boulevard Rene Branquart 80 7860 Lessines, Belgium for final release testing and product release functions of the Coseal Surgical Sealant Spray Set (Coseal Spray Set).
Source documents
Other decisions for Baxter Bio Science
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.